Filter
2046
Filtered Results: 2046
Text search:
preventable
diseases
Featured
Recommendations
195
New Publications
617
Language
Document type
No document type
1131
Studies & Reports
362
Guidelines
229
Strategic & Response Plan
118
Manuals
86
Fact sheets
48
Training Material
27
Situation Updates
20
Resource Platforms
10
Infographics
9
Online Courses
3
Brochures
2
Videos
1
Countries / Regions
Global
120
India
91
Kenya
62
Ethiopia
60
Sierra Leone
51
South Africa
44
Liberia
42
Nigeria
39
Uganda
38
Latin America and the Carribbean
38
Nepal
35
Bangladesh
35
Myanmar / Burma
34
Africa
34
Malawi
31
Western and Central Europe
29
Zambia
26
Ukraine
25
Ghana
24
Namibia
22
Philippines
21
Tanzania
20
Rwanda
16
Mozambique
16
South–East Asia Region
16
Venezuela
15
Congo, Democratic Republic of
13
Zimbabwe
13
Syria
13
Asia
13
Guinea
11
Yemen
11
South Sudan
10
Indonesia
10
East and Southern Africa
10
Pakistan
9
Botswana
9
Middle East and North Africa
9
Eastern Europe
8
Cambodia
7
Eswatini/ Swaziland
7
Brazil
7
West and Central Africa
7
Burkina Faso
6
Cameroon
6
Haiti
6
Argentina
6
Lesotho
6
Eastern Europe and Central Asia
6
Paraguay
6
Senegal
5
Mali
5
Somalia
5
Afghanistan
5
Thailand
5
Sudan
5
Peru
5
Chile
5
Western Pacific Region
5
Papua New Guinea
4
Central African Republic
4
Colombia
4
USA
3
Lebanon
3
Jordan
2
Turkey
2
North Macedonia
2
Ecuador
2
Madagascar
2
Mexico
2
Southern Africa
2
Moldova
2
Kyrgyzstan
2
North America
2
Jamaica
2
Guinea-Bissau
1
Iraq
1
Egypt
1
China
1
Benin
1
Hungary
1
Burundi
1
Bolivia
1
Libya
1
Angola
1
Poland
1
Albania
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Russia
1
Bulgaria
1
Romania
1
Slovakia
1
Iran
1
Kazakhstan
1
Georgia
1
Uruguay
1
Denmark
1
Maldives
1
United Kingdom
1
Portugal
1
Spain
1
Azerbaijan
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
862
Clinical Guidelines
226
Public Health
162
Women & Child Health
159
Key Resources
78
Capacity Building
22
Pharmacy & Technologies
13
Annual Report MEDBOX
2
Toolboxes
COVID-19
140
Mental Health
112
TB
92
HIV
90
Rapid Response
69
Conflict
64
Planetary Health
64
Disability
63
Caregiver
62
NCDs
56
AMR
54
NTDs
49
Global Health Education
45
Ebola
35
Refugee
31
Polio
27
Natural Hazards
22
Pharmacy
22
Health Financing Toolbox
20
Cholera
10
Zika
6
Social Ethics
3
Specific Hazards
2
South Sudan
1
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessmen...
The Kenya Health Policy 2014-2030 aims at attaining the highest possible standard of health in a manner responsive to the health needs of our population. One of the major policy directions towards realizing the intentions of this policy is to halt and reverse the
rising burden of non-communicable <....
Case Manangement Training Modules
Policy Brief | April 2015 | This brief accompanies the data sheet, Addressing Risk Factors for Noncommunicable Diseases Among Young People in Africa: Key to Prevention and Sustainable Development, and its data appendix, which provide all available c...
Reading Material for ASHA no.8
The devastating impacts of the 2015–16 El Niño will be felt well into 2017. This crisis was predicted, yet overall, the response has been too little too late. The looming La Niña event may further hit communities that are already deeply vulnerable. To end this cycle of failure, there is an urgen...
School health programmes have been demonstrated to be the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions aimed at reducing the main modifiable risk behaviours f...
School health programmes are the most cost-effective way to influence health behaviours in young people. The purpose of this two-part handbook is to support schools as they seek to implement interventions in order to reduce the main modifiable risk behaviours for noncommunicable .... This Practical application handbook provides advice to schools on providing young people with the knowledge, attitudes, beliefs and life skills necessary for making informed decisions, and creating a healthy school environment that can reduce the risk of NCDs
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an in...
Climate change is increasing the risks of injuries, diseases, and deaths globally. However, the association between ambient temperature and renal diseases has not been fully characterized. This stud...
Noncommunicable diseases (NCDs) are the principal cause of morbidity, disability and premature mortality in Azerbaijan. The most effective way to reduce the NCD burden is to prevent NCD development, by addressing thebehavioural risk factors un...
access free courses in more than 60 languages
While virtually unheard of in developed countries, NTDs are a group of medically diverse parasitic and bacterial infectious diseases common in tropical and subtropical areas. NTDs affect more than 1.5 billion people annually, causing death, blindnes...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region wa...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable ... (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
